Publications by authors named "Sarah Rutherford"

Claim this Profile
C
Consensus Recommendations from the 2024 International Follicular Lymphoma Scientific Workshop.
Reid W Merryman, Sarah C Rutherford, Stephen M Ansell, Philippe Armand, John P Leonard

Blood Adv· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular subtypes of DLBCL: are we ready to translate our knowledge into the change of treatment paradigms?
Sarah C Rutherford

Hematology Am Soc Hematol Educ Program· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of tafasitamab and lenalidomide in large B-cell lymphoma based on prior CD19-directed CAR T exposure.
Mwanasha H Merrill, Robert A Redd, Nicholas Lambert, Paolo F Caimi, Priyanka Pullarkat, Sarah C Rutherford

Hemasphere· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MRD-driven Initial Therapy of Acalabrutinib and Lenalidomide plus Rituximab (ALR) or Obinutuzumab (ALO) for Mantle Cell Lymphoma.
Jia Ruan, David A Bond, Bijal D Shah, John N Allan, Sarah C Rutherford

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of follicular lymphoma management: strategies on the horizon.
Erin Mulvey, Sarah C Rutherford, John P Leonard

Blood· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
Sarah C Rutherford, Hongli Li, Alex F Herrera, Michael LeBlanc, Sairah Ahmed

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic discussions in patients with advanced lymphoma: Characteristics and challenges.
Meghan McDarby, Jaime Gilliland, Rinchen Dolma, Sarah C Rutherford, Peter Martin

Palliat Support Care· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
Alex F Herrera, Michael LeBlanc, Sharon M Castellino, Hongli Li, Sarah C Rutherford

N Engl J Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Management of older patients with Hodgkin lymphoma: implications of S1826.
Marshall McKenna, Yun Kyoung Ryu Tiger, Sarah C Rutherford, Andrew M Evens

Semin Hematol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of imaging frequency on progression-free survival in Alliance trials enrolling patients with follicular lymphoma.
Sarah C Rutherford, Jun Yin, Levi D Pederson, Kristie A Blum, Peter Martin

Blood Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
XPO1 Enables Adaptive Regulation of mRNA Export Required for Genotoxic Stress Tolerance in Cancer Cells.
Rossella Marullo, Sarah C Rutherford, Maria V Revuelta, Nahuel Zamponi, Biljana Culjkovic-Kraljacic

Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study.
David A Qualls, Nicholas Lambert, Paolo F Caimi, Mwanasha Merrill, Priyanka Pullarkat, Sarah C Rutherford

Blood· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter phase 2 study of oral azacitidine (CC-486) plus CHOP as initial treatment for PTCL.
Jia Ruan, Alison Moskowitz, Neha Mehta-Shah, Lubomir Sokol, Zhengming Chen, Sarah C Rutherford

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.
Sarah C Rutherford, Jun Yin, Levi Pederson, Gabriela Perez Burbano, Betsy LaPlant

J Clin Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes Among Classical Hodgkin Lymphoma Patients After an Interim PET Scan: A Real-World Experience.
Muhammad Saad Hamid, Sarah C Rutherford, Hyejeong Jang, Seongho Kim, Krish Patel

Clin Lymphoma Myeloma Leuk· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unmet mental health needs in patients with advanced B-cell lymphomas.
Chrystal Marte, Login S George, Sarah C Rutherford, Daniel Jie Ouyang, Peter Martin

Palliat Support Care· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma.
Michael Dickinson, Javier Briones, Alex F Herrera, Eva González-Barca, Nilanjan Ghosh, Sarah C Rutherford

Blood Adv· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study.
Sarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, Stefan K Barta, Nadia Khan

Lancet Haematol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the prognostic utility of bone marrow biopsy in diffuse large B-Cell lymphoma in the SEER-Medicare dataset.
Danny Luan, Yiyuan Wu, Jordan Goldstein, Sarah Rutherford, John P Leonard

Leuk Lymphoma· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma.
Nina Orfali, Yuliya Jhanwar, Calvin Koo, Michelle Pasciolla, Maria Baldo, Sarah C Rutherford

Leuk Lymphoma· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Illness Understanding and Advance Care Planning in Patients with Advanced Lymphoma.
Kelly M Trevino, Sarah C Rutherford, Chrystal Marte, Daniel Jie Ouyang, Peter Martin

J Palliat Med· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of bone marrow biopsy on response assessment in immunochemotherapy-treated lymphoma patients in GALLIUM and GOYA.
Sarah C Rutherford, Michael Herold, Wolfgang Hiddemann, Lale Kostakoglu, Robert Marcus

Blood Adv· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of palbociclib plus bortezomib in previously treated mantle cell lymphoma.
Peter Martin, Jia Ruan, Richard Furman, Sarah Rutherford, John Allan

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation.
Kah Poh Loh, Andrea Baran, Christina Y Lee, Alfadel Alshaibani, Sarah C Rutherford

Leuk Lymphoma· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surveillance scanning in lymphoma.
Sarah C Rutherford

Clin Adv Hematol Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis